Mangrove Partners’s NeoGenomics NEO Stock Holding History

Mangrove Partners’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-87,935	Closed	-$643K	–	224
2025 Q2	$643K	Buy	+87,935	New	+$710K	0.07%	121

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mangrove Partners's NEO Position: Q3 2025 in Review

Mangrove Partners sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 87,935 shares — an estimated $643K sold.

Mangrove Partners first reported a position in NEO in Q2 2025 and held it in 1 quarter. The position peaked at $643K in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

Mangrove Partners reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
Mangrove Partners sold 87,935 NeoGenomics shares in Q3 2025, an estimated $643K.
Mangrove Partners first reported a position in NeoGenomics in Q2 2025 and held it in 1 quarter.
Mangrove Partners's NeoGenomics position peaked at $643K in Q2 2025.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Mangrove Partners's 13F filing for Q3 2025, filed 14 Nov 2025.